The authors discuss how more efforts need to ensure the methods used to measure the “value” of new therapies include factors that reflect patient heterogeneity.
Amy Miller, PhD
Advertisement
Articles by Amy Miller, PhD
Advertisement
Latest Updated Articles
- Why Accounting for Our Differences Matter in Assessing Drug Value
Published: June 1st 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance
3
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
4
Medical School Diversity Declines Following Affirmative Action Repeal
5
